Neogenesis Biotech › News & Events › Continuous Optimization of the Solid Tumor TIL Testing Workflow
Continuous Optimization of the Solid Tumor TIL Testing Workflow

Continuously improving TIL testing quality to build a more comprehensive tumor immunology analysis.
Tumor-Infiltrating Lymphocytes (TILs) are a cornerstone of tumor immunology research and cell therapy. Because immune cell composition, the tumor microenvironment, and levels of immunosuppression vary significantly between patients, establishing a standardized, high-quality TIL testing workflow is a vital step toward precision medicine.
Axiom Biotech is continuously optimizing its TIL testing workflow by integrating multi-color flow cytometry, AI Cell Report, and immune cell analysis technologies, with the goal of building a more comprehensive and consistent tumor immunology assessment platform.
Ready to start your precision medicine journey?
Contact our experts to learn about cellular intelligence and health management.
More in Clinical Research and Trial Progress
Keep reading on related topics
What Are T Cells? Types, Functions and Their Role in Cancer and Autoimmune Disease
T cells are a type of lymphocyte among the white blood cells and a key part of adaptive immunity. Th…
Neogenesis Biotech and Taipei Veterans General Hospital Advance Research on Type 1 Diabetes and Regulatory T Cells (Tregs)
Neogenesis Biotech and the clinical team at Taipei Veterans General Hospital have finalized discussi…
Ongoing clinical research collaboration with Taipei Veterans General Hospital continues to advance.
Neogenesis Biotech partners with Taipei Veterans General Hospital to advance clinical research by in…
Companion Diagnostics and Precision Immune Cell Analysis: From Pre-Treatment Assessment and Post-Treatment Monitoring to Cell Manufacturing and Drug Development
A companion diagnostic (CDx) is a test that provides information essential for the safe and effectiv…
